Finance

Beta
Lists
AEON:NYSEAMERICAN
Aeon Biopharma Inc
$0.76
+5.64%
(+0.040) 1D
$0.72
-4.77% (-0.036)
After hours
Closed: May 29, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AEON...
Open
$0.71
High
$0.76
Low
$0.71
Mkt. cap
19.80M
Avg. vol.
81.19K
Volume
35.28K
52-wk high
$1.45
52-wk low
$0.53
EPS
-$4.16
Beta
0.66
Shares outstanding
26.31M
No. of employees
8
Open
$0.71
High
$0.76
Low
$0.71
Mkt. cap
19.80M
Avg. vol.
81.19K
Volume
35.28K
52-wk high
$1.45
52-wk low
$0.53
EPS
-$4.16
Beta
0.66
Shares outstanding
26.31M
No. of employees
8
News stories
From sources across the web
Profile
Alphaeon Corporation is a company focused on healthcare products and services based in Irvine, California. Alphaeon Corporation serves healthcare providers in the self-pay segment; primarily plastic surgery, ophthalmology, dentistry, and dermatology. Wikipedia
About Aeon Biopharma Inc
CEOMurthy Simhambhatla
Employees8
Founded2013
HeadquartersIrvine, California, United States
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.06M
597.00K
1.61M
2.03M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.26M
2.33M
3.49M
3.90M
Operating expense
4.32M
2.93M
5.10M
5.94M
Total operating expenses
4.32M
2.93M
5.10M
5.94M
Operating income
-4.32M
-2.93M
-5.10M
-5.94M
Other non operating income
-450.00K
-168.00K
-14.08M
2.94M
EBT including unusual items
-6.64M
-4.54M
-37.14M
-11.79M
EBT excluding unusual items
-4.77M
-3.10M
-19.18M
-2.99M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-6.64M
-4.54M
-37.14M
-11.79M
Net profit margin
-
-
-
-
Earnings per share
-0.60
-0.39
-3.72
-0.25
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-4.30M
-2.91M
-5.08M
-5.92M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more